Master of Musical Chairs
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
prayers like that go unanswered
not enough volume to confirm double bottom...... going lower I'm saying manifest the dimes
i have alerts set no need to watch i did enough watching last year .. God speed
trips won't ever be back here.... .08 - .10
no float lock up here too many shares floating around after the failed kodiak law suit plenty of shares out there
not here to save anyone just speaking my mind and no comment
do they have a horse running in the Kentucky derby?
much more blood will be shed .08-.10 coming
no comment
audit completion sends it
Holding 2m shares here may the winds be at our back to Silver and Beyond
has nothing to do with OMHE
after audit watch this go kabooma
i like thus stock
whos gonna pay for it? this all costs money
good thing they waited until now to sell
its a beautiful thing thank you again for the alert around .01 God Bless your soul
agreed also great they a building on core.business that doesnt revolve around cannabis much easier to raise funding this way
Omni Health Announces Upcoming Opening of Functional Medicine Clinic With Focus on Anti-Aging and Aesthetic Treatments OMHE
Omni Health Announces Upcoming Opening of Functional Medicine Clinic With Focus on Anti-Aging and Aesthetic Treatments Miami, FL, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Omni Health, Inc. (OTC:OMHE), a vertically integrated healthcare company dedicated to the development of pharmaceuticals, anti-aging products, and biotech engineering, today announced upcoming opening of Functional Medicine Clinic with focus on anti-aging and aesthetic treatments. Omni Health is in the process of leasing its first state of the art facility to offer high-end and convenient location in trendy South Miami area. The new facility will offer the latest anti-aging regenerative medicine solutions. The following are among treatments which will be available at the new clinic: -- Bioidentical hormone therapy -- Medical weight loss management -- Nutrient supplements -- Detoxification -- I.V. Nutritional Therapy -- Wellness coaching -- Therapies for insomnia, migraines, and stress -- Stem Cell Regeneration Treatments -- Aesthetic treatments such as Botox(R) and Juviderm(R) injections and laser hair removal "With over 10 years' experience in the field of anti-aging we are extremely pleased with this latest development to fulfill the ever-strong demand for anti-aging treatments," said Andrey Soloviev, Omni Health's CEO. "Anti-aging medicine is a rapidly growing field fueled not only by the growing population of retirees but by both males and females from significantly younger age groups. By being able to offer the full specter of anti-aging treatments we will fulfill our earlier promise to shareholders to position our Company as an emergent, dominant presence in key, lucrative markets." The market research firm Global Industry Analysts estimates that a boomer fueled consumer base "seeking to keep the dreaded signs of aging at bay" will push US market for anti-aging products and services from about $80 billion now to more than $114 billion by 2020. The Company anticipates completing all necessary licensing requirements and begin operating the new facility in December 2018 with the ultimate goal of opening a network of such clinics nationwide and becoming a leader in anti-aging medicine and integrative health management. Company anticipates pro-forma annual revenue of $7,500,000 per clinic. Safe Harbor Statement Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies. Contact: Andrey Soloviev CEO ceo@OmniHealth.md (END) Dow Jones Newswires February 28, 2018 07:00 ET (12:00 GMT) Story ID: 20180228SN008148 Keywords: COMPANY NEWS, DOW JONES CONTENT SET SN, PRESS RELEASE WIRES, TOBACCO, GRAND CENTRAL ASSET CLASS EQUITIES, CONSUMER GOODS, GLOBENEWSWIRE, SIGNIFICANT STORY Symbols: OMHE
Omni Health Announces Upcoming Opening of Functional Medicine Clinic With Focus on Anti-Aging and Aesthetic Treatments OMHE
Omni Health Announces Upcoming Opening of Functional Medicine Clinic With Focus on Anti-Aging and Aesthetic Treatments Miami, FL, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Omni Health, Inc. (OTC:OMHE), a vertically integrated healthcare company dedicated to the development of pharmaceuticals, anti-aging products, and biotech engineering, today announced upcoming opening of Functional Medicine Clinic with focus on anti-aging and aesthetic treatments. Omni Health is in the process of leasing its first state of the art facility to offer high-end and convenient location in trendy South Miami area. The new facility will offer the latest anti-aging regenerative medicine solutions. The following are among treatments which will be available at the new clinic: -- Bioidentical hormone therapy -- Medical weight loss management -- Nutrient supplements -- Detoxification -- I.V. Nutritional Therapy -- Wellness coaching -- Therapies for insomnia, migraines, and stress -- Stem Cell Regeneration Treatments -- Aesthetic treatments such as Botox(R) and Juviderm(R) injections and laser hair removal "With over 10 years' experience in the field of anti-aging we are extremely pleased with this latest development to fulfill the ever-strong demand for anti-aging treatments," said Andrey Soloviev, Omni Health's CEO. "Anti-aging medicine is a rapidly growing field fueled not only by the growing population of retirees but by both males and females from significantly younger age groups. By being able to offer the full specter of anti-aging treatments we will fulfill our earlier promise to shareholders to position our Company as an emergent, dominant presence in key, lucrative markets." The market research firm Global Industry Analysts estimates that a boomer fueled consumer base "seeking to keep the dreaded signs of aging at bay" will push US market for anti-aging products and services from about $80 billion now to more than $114 billion by 2020. The Company anticipates completing all necessary licensing requirements and begin operating the new facility in December 2018 with the ultimate goal of opening a network of such clinics nationwide and becoming a leader in anti-aging medicine and integrative health management. Company anticipates pro-forma annual revenue of $7,500,000 per clinic. Safe Harbor Statement Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies. Contact: Andrey Soloviev CEO ceo@OmniHealth.md (END) Dow Jones Newswires February 28, 2018 07:00 ET (12:00 GMT) Story ID: 20180228SN008148 Keywords: COMPANY NEWS, DOW JONES CONTENT SET SN, PRESS RELEASE WIRES, TOBACCO, GRAND CENTRAL ASSET CLASS EQUITIES, CONSUMER GOODS, GLOBENEWSWIRE, SIGNIFICANT STORY Symbols: OMHE
why are they talking about California? What happened to Europe? Its going to take 2-3 years before we could sell in USA
I agree its only money who cares if you can buy it for 50% cheaper in a week
you have all year to load... new time lines show 2019 as potential market launch...
I would wait for low .20s and maybe even a retest of .08-.10
lets see if it holds .35 if not uh oh
lmfaoooooooooooooo like i said .38 strong resistance now
none what so ever until something changes.. sure delays happen but the public has never been fully updated on those changes... we have been kept in the dark to make assumptions, first and foremost WHAT EVER HAPPENED TO EUROPE MARKET???? its funny NOW they want to blame California for the TSX listing when WE WERE TOLD $OWCP will be entering the EU market first and foremost... then POOF NOTHING.. so until something changes, I have no faith and I hold no position here
lmfao guess what shmansky .38 is now resistance maybe I will buy lower
lol hey .38 would ya look at that lmfao $OWCP
PM me your email please I have something to share
k I'll get back to making money here hold my beer ill be right back lmfaoooooo
presentations will follow a reading of the safe harbor lmfaoooooooo see ya at .38
so they can sell more shares to willing investors lmfao they need money to conduct research trials cost money especially when theyre year +out from product potential revenue....
happy lunar New Year of the Dog $JD $55+ BY EARNINGS 3/2
They offered me .70 and 1.40 when the price was over $1
yea .70 and 1.40 lol I'm sure they will be asking for .25 .50 this time around to lure some new money in or maybe .40 .80 warrants but hey musical shares just don't be left holding the bag
so glad I sold over .04 and scaling back in under .02
scam is wrong word.. sophisticated Ponzi